COMT mRNA Levels in Brain Tissue and Psychiatric Disorders
Author Information
Author(s): Emma L Dempster, Jonathan Mill, Ian W Craig, David A Collier
Primary Institution: Institute of Psychiatry, London, UK
Hypothesis
Is the expression of COMT mRNA altered in individuals with schizophrenia, bipolar disorder, and depression?
Conclusion
COMT expression is not altered in the cerebellum of individuals with schizophrenia, bipolar disorder, or depression, but is influenced by specific genetic polymorphisms.
Supporting Evidence
- COMT expression levels were not significantly different across the diagnostic groups studied.
- Genotype at three COMT SNPs was associated with gene expression levels.
- Females exhibited significantly higher levels of COMT mRNA compared to males.
Takeaway
This study looked at brain samples to see if a gene called COMT is different in people with mental illnesses, but it found that the gene's activity is mostly the same across different conditions.
Methodology
Quantitative RT-PCR was used to measure COMT mRNA levels in post mortem cerebellum samples from individuals with various psychiatric diagnoses.
Limitations
The study's findings may be limited by the lack of specificity of the COMT probe used and the focus on a single brain region.
Participant Demographics
15 samples each from individuals diagnosed with schizophrenia, bipolar disorder, depression, and 15 controls with no history of mental illness.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website